Wednesday, March 29, 2017 11:19:06 AM
The Co.'s market cap is trading at 1/3 of the potential value of K's approval from the FDA for it's Orphan Drug treatment of retinoblastoma, which affords the opportunity to apply for a "Rare Pediatric Disease Review" Voucher which can be sold and in fact have been sold for hundreds of millions of dollars.
This does not include the potential value of B's use as a treatment for biofilm infections in prosthetic orthopedic infections. Orthopedic infection continues to receive a high level of attention, due to the fact that nearly 1 million total hip and knee arthroplasties are performed in the USA each year, and this number is expected to rise in the near term with the aging population. The market is giving no credit to these adjunct applications and little to no value to B,P and K platforms combined.
I'ts clear that retail investors, currently the only holders (not including insiders) are scared to death and are sitting on their wallets until the price action supports their thesis for holding CTIX as an investment.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM